Showing results (171-180 of 199) with videos related to

Sort By:
Pageof 20
Haematologica|January 22, 2026
Chronic graft-versus-host disease in the era of post-transplant cyclophosphamidePedro Asensi Cantò, Juan Montoro, Aitana Balaguer-Roselló, et al.
Hemasphere|April 17, 2025
Caplacizumab treatment in elderly patients with iTTP: Experience from the Spanish TTP RegistryInés Gómez-Seguí, Joan Cid, Miquel Lozano, et al.
Cancers|August 14, 2025
Cardiotoxicity in Adult Patients with Relapsed or Refractory Acute Myeloid LeukemiaLaura Torres-Miñana, Blanca Boluda, Antonio Solana-Altabella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple MyelomaJuan-Jose Garcés, Maria-Teresa Cedena, Noemi Puig, et al.
Cancers|October 27, 2022
NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical TrialJuan Manuel Rosa-Rosa, Isabel Cuenca, Alejandro Medina, et al.
The New England Journal of Medicine|September 4, 2014
Lenalidomide and dexamethasone in transplant-ineligible patients with myelomaLotfi Benboubker, Meletios A Dimopoulos, Angela Dispenzieri, et al.
Lancet (London, England)|January 19, 2016
Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trialSagar Lonial, Brendan M Weiss, Saad Z Usmani, et al.
Leukemia & Lymphoma|October 20, 2021
Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patientsJosé Luis Piñana, Lourdes Vázquez, Rodrigo Martino, et al.
Leukemia|December 14, 2018
Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosisNoemi Puig, Bruno Paiva, Marta Lasa, et al.
Pageof 20